FDA Drug Approval, A209252, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
FDA Drug Approval, A209252, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 209252
Company: GLENMARK SPECLT
Drug Name: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Active Ingredients: BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Strength: 5%;EQ 1% BASE
Dosage Form/Route: GEL;TOPICAL
Action Date: 03/14/2019
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: GLENMARK SPECLT
Drug Name: CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Active Ingredients: BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Strength: 5%;EQ 1% BASE
Dosage Form/Route: GEL;TOPICAL
Action Date: 03/14/2019
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details